Leadership Overview
Sentiss Pharma Pvt has 4 executives leading key functions including strategy, finance, human resources, and financial analysis.
Driven by a commitment to quality, Sentiss Pharma Pvt specializes in delivering innovative ophthalmic, inhalation, otic, and nasal drop products, enhancing global healthcare outcomes.
Driven by a commitment to quality, Sentiss Pharma Pvt specializes in delivering innovative ophthalmic, inhalation, otic, and nasal drop products, enhancing global healthcare outcomes.
Leadership Roles at Sentiss Pharma Pvt
Deepak Bahri - Founder & Chief Executive Officer
Deepak Bahri, the Founder & Chief Executive Officer at Sentiss Pharma Pvt, architects the company's overarching strategy and global vision. Bahri directs the development and execution of innovative healthcare solutions, focusing on high-quality ophthalmic, inhalation, otic, and nasal drop products. Overseeing all strategic initiatives, the Founder & Chief Executive Officer ensures alignment with Sentiss Pharma Pvt's mission to improve health outcomes worldwide. This leadership role involves fostering a culture of quality and social responsibility across all operations. By guiding product portfolio expansion, Deepak Bahri drives the company's market presence and commitment to specialty pharmaceuticals. Bahri's strategic direction solidifies Sentiss Pharma Pvt's position as a trusted provider of niche healthcare solutions.
Debajit Sensharma - Chief Financial Officer
Debajit Sensharma, the Chief Financial Officer at Sentiss Pharma Pvt, manages all financial operations and fiscal strategy. Sensharma oversees budgeting, financial planning, and resource allocation to support the company's growth in specialty pharmaceuticals. This executive ensures robust financial controls and compliance with global regulatory standards, safeguarding the company's assets. By analyzing financial performance, the Chief Financial Officer provides critical insights to drive informed decision-making across departments. Debajit Sensharma's leadership in financial management supports Sentiss Pharma Pvt's commitment to quality and social responsibility. Sensharma's expertise is vital for maintaining the company's financial health and enabling its expansion into new markets with innovative healthcare solutions.
Joyeeta Chatterjee - Chief Human Resources Officer
Joyeeta Chatterjee, the Chief Human Resources Officer at Sentiss Pharma Pvt, leads all human capital strategies and organizational development. Chatterjee cultivates a positive and productive work environment, reinforcing Sentiss Pharma Pvt's recognition as a Great Place to Work. This role involves developing talent acquisition, retention, and employee engagement programs that align with the company's mission. Overseeing employee relations and HR policies, the Chief Human Resources Officer ensures a supportive culture that fosters innovation and quality. Joyeeta Chatterjee's focus on employee satisfaction and community engagement is integral to the company's sustained success. Chatterjee's leadership drives the human resources function, supporting the delivery of high-quality ophthalmic, inhalation, otic, and nasal drop products globally.
Sooraj Oswal - Cfa
Sooraj Oswal, the Cfa at Sentiss Pharma Pvt, provides critical financial analysis and strategic investment insights. Oswal supports the Chief Financial Officer in evaluating financial performance and identifying opportunities for fiscal optimization. This role involves rigorous analysis of market trends and company financials to inform strategic planning for specialty pharmaceutical products. By conducting detailed financial modeling, the Cfa contributes to the company's commitment to quality and social responsibility. Sooraj Oswal's analytical expertise is essential for assessing the financial viability of new product development and market expansion initiatives. Oswal's contributions ensure that Sentiss Pharma Pvt maintains a strong financial foundation while pursuing its mission of delivering innovative healthcare solutions.
Explore Leadership Teams in Manufacturing
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership JV
SP
AM
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership
BB
YK
TK
Biophore specializes in the development and manufacturing of niche pharmaceutical products, focusing on APIs and intermediates for the global pharmaceutical industry. The company aims to enable its clients to reach the market quickly, ensuring faster access to patients. With a diverse product range and expertise in complex chemistry, Biophore is a trusted partner for collaborative projects. Their operations are supported by US FDA and EU approved manufacturing facilities, emphasizing quality and innovation.
Company Leadership RL
SA
KK
Alkermes plc is a global biopharmaceutical enterprise that specialises in developing and commercialising innovative medicines for people living with complex psychiatric and neurological disorders. Headquartered in Dublin, Ireland, the company combines deep neuroscience expertise with patient‑inspired science to pursue treatments for conditions such as addiction, schizophrenia, bipolar disorder, opioid dependence and other central nervous system diseases. Its approach integrates scientific research, clinical development and specialised commercial infrastructure to deliver both marketed medicines and investigational candidates, aiming to address serious unmet medical needs and improve how chronic neurological and mental health conditions are managed.
Company Leadership
SS

JS